Thermal endometrial ablation data requirements for amenorrhea claim slated for panel review Jan. 27.

THERMAL ENDOMETRIAL ABLATION DATA REQUIREMENTS FOR AMENORRHEA INDICATION will be discussed by FDA's Obstetrics and Gynecology Devices Panel on Jan. 27, beginning at 12:30 p.m. at FDA's Corporate Building. On Jan. 29, the panel will review a product development protocol in closed session.